AIMS: To measure reduction in exposure to smoke in two population-based studies of self-reported smoking reduction not using nicotine replacement. DESIGN: Cross-sectional analyses of biomarkers and smoking. SETTING: Data from two time-points in the Copenhagen City Heart Study (CCHS), 1981/83 and 1991/94, and the Copenhagen Male Study (CMS) in 1976 and 1985/86, respectively. PARTICIPANTS: There were 3026 adults who were smokers at both time-points in the CCHS and 1319 men smoking at both time-points in the CMS. MEASUREMENTS: Smoking status and tobacco consumption were assessed by self-completion questionnaire. Measurements of biomarkers of smoke intake were taken at the second time-point in the two studies: expired-air carbon monoxide (CO) in the CCHS and serum cotinine in the CMS. Biomarker levels in medium (15-29 g tobacco/day) and heavy (> 30 g/day) smokers at the first time-point who later reported a reduction in cigarettes per day of 50% or more without quitting were compared with continuing medium, heavy and light smokers (1-14 g/day) using linear regression. Sex (CCHS only), age, self-reported inhalation of smoke, duration of smoking, type of tobacco and amount smoked were included as covariates in multivariate models. FINDINGS: Heavy smokers who reduced did not show lower levels of biomarkers at follow-up. Medium smokers who reduced showed a reduction in cotinine but not CO. The reduction in cotinine was not commensurate with the reported reduction in consumption. CONCLUSIONS: Long-term reductions in self-reported tobacco smoking are probably associated with, at best, modest reductions in smoke exposure.
AIMS: To measure reduction in exposure to smoke in two population-based studies of self-reported smoking reduction not using nicotine replacement. DESIGN: Cross-sectional analyses of biomarkers and smoking. SETTING: Data from two time-points in the Copenhagen City Heart Study (CCHS), 1981/83 and 1991/94, and the Copenhagen Male Study (CMS) in 1976 and 1985/86, respectively. PARTICIPANTS: There were 3026 adults who were smokers at both time-points in the CCHS and 1319 men smoking at both time-points in the CMS. MEASUREMENTS: Smoking status and tobacco consumption were assessed by self-completion questionnaire. Measurements of biomarkers of smoke intake were taken at the second time-point in the two studies: expired-air carbon monoxide (CO) in the CCHS and serum cotinine in the CMS. Biomarker levels in medium (15-29 g tobacco/day) and heavy (> 30 g/day) smokers at the first time-point who later reported a reduction in cigarettes per day of 50% or more without quitting were compared with continuing medium, heavy and light smokers (1-14 g/day) using linear regression. Sex (CCHS only), age, self-reported inhalation of smoke, duration of smoking, type of tobacco and amount smoked were included as covariates in multivariate models. FINDINGS: Heavy smokers who reduced did not show lower levels of biomarkers at follow-up. Medium smokers who reduced showed a reduction in cotinine but not CO. The reduction in cotinine was not commensurate with the reported reduction in consumption. CONCLUSIONS: Long-term reductions in self-reported tobacco smoking are probably associated with, at best, modest reductions in smoke exposure.
Authors: Ellen D Jorgensen; Hong Zhao; Frank Traganos; Anthony P Albino; Zbigniew Darzynkiewicz Journal: Cell Cycle Date: 2010-06-01 Impact factor: 4.534
Authors: Carole K Holahan; Charles J Holahan; Daniel A Powers; Rashelle B Hayes; C Nathan Marti; Judith K Ockene Journal: Nicotine Tob Res Date: 2011-04-19 Impact factor: 4.244
Authors: Anthony P Albino; Ellen D Jorgensen; Patrick Rainey; Gene Gillman; T Jeffrey Clark; Diana Gietl; Hong Zhao; Frank Traganos; Zbigniew Darzynkiewicz Journal: Mutat Res Date: 2009-07-08 Impact factor: 2.433
Authors: Carole K Holahan; Charles J Holahan; Rebecca J North; Rashelle B Hayes; Daniel A Powers; Judith K Ockene Journal: Nicotine Tob Res Date: 2012-09-10 Impact factor: 4.244
Authors: Craig S Parzynski; Maria Jaszyna-Gasior; Frederick H Franken; Eric T Moolchan Journal: Pharmacol Biochem Behav Date: 2007-12-08 Impact factor: 3.533
Authors: Brian L Rostron; Catherine G Corey; Joanne T Chang; Dana M van Bemmel; Mollie E Miller; Cindy M Chang Journal: Nicotine Tob Res Date: 2020-10-08 Impact factor: 4.244